Who should and should not use GHK-CU GHK-CU suits many research applications but is not appropriate for everyone
McElya at Neighborhood Medical Center in Dallas can help you assess your needs and decide the best option for you
Initially, GLP-1s were developed to treat type 2 diabetes and were marketed for that purpose under brand names such as Ozempic (semaglutide), Rybelsus (semaglutide), Victoza (liraglutide), and Mounjaro (tirzepatide)
It presents the rationale as metabolic support, addressing deficiencies common during rapid weight loss, and notes individual responses vary with baseline nutritional status, liver function, and metabolic rate
Suenderhauf, C., Hammann, F
But heres something most people dont realize: your body already makes GLP-1